Apellis Pharmaceuticals | 10-Q: Quarterly report
Apellis Pharmaceuticals | DEF 14A: Definitive information statements
Apellis Pharmaceuticals | ARS: Annual Report to Security Holders
Apellis Pharmaceuticals | DEFA14A: Others
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Deschatelets Pascal
Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene
Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair
Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DeLong Mark Jeffrey
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chopas James George
Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nicholson Nur
Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Deschatelets Pascal
Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data